glp-1 incretin is released from the small intestine after meal ingestion and GIP and GLP‐1, the two

How do GLP-1 weight loss programs work

Once-monthly maridebart cafraglutide for the treatment of obesity - A phase 2 trial

Applying the patch for longer periods can lead to side effects such as: Erythema (redness) Pruritus (itching) Contact dermatitis Skin inflammation Burning sensation GLP-1 transdermal patches may also cause hypersensitivity reactions and skin sensitization after repeated exposure

It remains under active clinical evaluation for weight loss and metabolic disorders

GLP-1 Medications and NAION: What Patients Should Know About Sudden Vision Loss David B

Educational reference only not medical advice or a dosing recommendation